Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

New Delhi, Here are the latest updates on the <keyword id="8714274" type="UNKNOWN" weightage="20" keywordseo="coronavirus-crisis">coronavirus crisis</keyword> in India and other parts of the world on Wednesday. The Supreme Court on Wednesday took note of the Centre's guidelines and said posters and signages should not be affixed by authorities outside homes of <keyword id="8873995" type="UNKNOWN" weightage="20" keywordseo="COVID-19-patients">COVID-19 patients</keyword> in the country. Face shields alone are not highly effective to prevent COVID-19 infection without masks, says a new study which assessed what happens to the airflow around these plastic screens when someone nearby sneezes. In most of the COVID-19 deaths in WB comorbidities like hypertension, diabetes, cardiac problems, nephrotic syndrome and COPD were found to be fatal, a study conducted by <keyword id="9260641" type="COMPANY" weightage="20" keywordseo="the-state-health-department">the state health department</keyword> said. Actor <keyword id="210696" type="PERSON" weightage="20" keywordseo="Kriti-Sanon">Kriti Sanon</keyword> on Wednesday said she has tested positive for coronavirus and is currently under home quarantine. The Supreme Court on Wednesday took note of the Centre's guidelines and said that posters and signage should not be affixed by the authorities outside the homes of COVID-19 patients in the country. Twenty-two more people, including four army personnel and a <keyword id="1580087" type="POSITION" weightage="20" keywordseo="health-care-worker">health care worker</keyword>, tested positive for COVID-19 in Arunachal Pradesh, pushing the tally in the northeastern state to 16,437, a senior health official said here on Wednesday. The Mizoram government has launched a project to assist the migrant workers, who lost their jobs due to the COVID-19 pandemic, find suitable employment. The total coronavirus cases mounted to 97,35,850 with 32,080 new infections being reported in a day, while the death toll rose to 1,41,360 with 402 new fatalities, data updated by the ministry at 8 am showed. Andaman and Nicobar Islands COVID-19 tally rose to 4,778 as five more persons tested positive for the virus, a health department official said on Wednesday. US President-elect Joe Biden has said that in the first 100 days of his administration, he would mandate everyone to wear a mask, ensure 100 million COVID-19 vaccinations and reopen the majority of schools as he assured Americans that his "crisis-tested" team of experts will deliver better healthcare and revive the economy. Nine more people, including four <keyword id="109513" type="COMPANY" weightage="20" keywordseo="Border-security-force">Border Security Force</keyword> (BSF) jawans have tested positive for COVID-19 in Mizoram, pushing the state's coronavirus tally to 3,977, an official said on Wednesday. Jharkhand's COVID-19 tally mounted to 1,10,639 as 182 more people tested positive for the virus, a health department official said on Wednesday. US President-elect Joe Biden has nominated Dr Vivek Murthy as his Surgeon General, exuding confidence that the renowned Indian-American physician will be a key voice on his response to the coronavirus pandemic to restore public trust and faith in science and medicine. President Donald Trump has signed an executive order that prioritises Americans' access to COVID-19 vaccines before the US potentially begins helping other nations. SEE ALSO: <a href="https://www.businessinsider.in/business/telecom/news/mukesh-ambani-says-jio-will-rollout-5g-services-by-june-2021-and-it-will-go-beyond-india/articleshow/79619222.cms">Mukesh Ambani says Jio will rollout 5G services by June 2021 – and it will go beyond India</a> <a href="https://www.businessinsider.in/stock-market/news/top-stocks-to-watch-canara-bank-sun-pharma-titan-nbcc-gujarat-state-fertilizers-coffee-day-and-others/articleshow/79617464.cms">Top stocks to watch — Canara Bank, Sun Pharma, Titan, NBCC, Gujarat State Fertilizers, Coffee Day, and others</a>

COVID-19 crisis: Here are all the latest updates from India and around the world

<ul><li>An ayurvedic drug called ZingiVir-H has been approved for conducting clinical trials on coronavirus patients in India by the Clinical Trial Registry of India (CTRI). </li><li>The sample size of the study is 112 patients with 15 Covid-19 positive patients already enrolled. </li><li>Hareendran Nair, the founder of the Pankajaksthuri Herbal Research Foundation in Kerala where the drug was developed, believes the results of trials will be available by the end of May. </li></ul>An ayurvedic drug in India called ZingiVir-H has gotten the rubber stamp to conduct clinical trials on adults who have tested positive for coronavirus in India. Currently, it’s only being tested at the Mysore Medical College and Research Institute (MMCRI) with a sample size of 112 patients with 15 people already enrolled — but it is open to recruitment. According to Hareendran Nair, the founder of the Pankajaksthuri Herbal Research Foundation in Kerala where the drug was developed, other medical colleges in Tamil Nadu, Karnataka, Maharashtra, Telangana and Delhi have also been approached. This is the first known ayurvedic approach to cure Covid-19. Testing ZingiVir-H as a drug for coronavirus The Clinical Trial Registry of India (<a href="http://ctri.nic.in/Clinicaltrials/showallp.php?mid1=43168&amp;EncHid=&amp;userName=Zingivir">CTRI</a>) has given the nod for a randomised controlled single-blind trial to find out if ZingiVir-H is safe and effective as a way to boost immunity in Covid-19 patients. That means while some patients in the trial will receive the drugs, others will receive a placebo. <div type="Article" hostid="261" msid="75470476" title="The curious case of Remdesivir — the coronavirus ‘miracle drug’ may be overhyped, suggests Lancet study" mstype="2" mssubtype="0"></div> According to Nair, ZingiVir-H has seven ingredients and he has been using the drug for the past 15 years to cure respiratory infections like viral fevers and acute viral bronchitis. For coronavirus, a 500 mg tablet will be given to patients every 3 hours between 6:00 am to 9:00 pm for at least 10 days, but no more than 15 days to determine the outcome. The clinical trials will measure a coronavirus patients’ improvement as per a 7-point ordinal scale to determine the odds ratio — the odds for improvement. On the day that a patient enters the trial will be the baseline, followed by recording time points on Day 7 and Day 15. “We are expecting the results by the end of May. I am not sure about the result. If the results are positive, then it would be the success of Ayurveda, and if not, then it will be my failure,” Nair told <a href="https://www.aninews.in/news/national/general-news/clinical-trial-of-ayurvedic-medicine-starts-on-covid-19-patients20200503184850/">ANI</a>. See also: <a href="https://www.businessinsider.in/science/health/news/remdesivir-the-coronavirus-miracle-drug-may-be-overhyped-suggests-lancet-study/articleshow/75470476.cms">The curious case of Remdesivir — the coronavirus ‘miracle drug’ may be overhyped, suggests Lancet study</a> <a href="https://www.businessinsider.in/india/news/coronavirus-drug-favipiravir-set-for-clinical-trials-by-indian-pharma-companies-strides-and-glenmark/articleshow/75465068.cms">Coronavirus drug Favipiravir set for clinical trials by Indian pharma companies Strides and Glenmark</a> <a href="https://www.businessinsider.in/science/news/were-repeating-one-of-the-worst-mistakes-of-the-ebola-outbreak-in-the-hunt-for-a-coronavirus-cure/articleshow/75434954.cms">We're repeating one of the worst mistakes of the Ebola outbreak in the hunt for a coronavirus cure</a>

An Indian ayurvedic drug is being tried on coronavirus patients in Mysore

<ul><li>The study, published on Thursday in the Journal of Pediatrics, found that the virus and antibodies can coexist in young patients.</li><li>This study used a retrospective analysis of 6,369 children tested for SARS-CoV-2, the virus that causes <keyword id="8763838" type="UNKNOWN" weightage="20" keywordseo="covid-19">Covid-19</keyword>, and 215 patients who underwent antibody testing at Children's National between March 13, 2020, and June 21, 2020. </li><li>The researchers found patients from six to 15 years old took a longer time to clear the virus (median of 32 days) compared to patients 16 through 22 years old (median of 18 days). </li></ul>In a crucial study, the researchers have found that children can be infected with the novel <keyword id="1754604" type="PERSON" weightage="20" keywordseo="coronavirus">coronavirus</keyword> (Covid-19), but have antibodies against the disease in their blood at the same time. The study, published on Thursday in the Journal of Pediatrics, found that the virus and antibodies can coexist in young patients. "With most viruses, when you start to detect antibodies, you won't detect the virus anymore. But with Covid-19, we're seeing both," said study lead author Burak Bahar from the Children's National Hospital in the US. "This means children still have the potential to transmit the virus even if antibodies are detected," Bahar added. This study used a retrospective analysis of 6,369 children tested for SARS-CoV-2, the virus that causes Covid-19, and 215 patients who underwent antibody testing at Children's National between March 13, 2020, and June 21, 2020. Out of the 215 patients, 33 had co-testing for both the virus and antibodies during their disease course. Nine of the 33 showed the presence of antibodies in their blood while also later testing positive for the virus. The study also assessed the timing of viral clearance and immunologic response. It found the median time from viral positivity to negativity when the virus can no longer be detected, was 25 days. The researchers found patients from six to 15 years old took a longer time to clear the virus (median of 32 days) compared to patients 16 through 22 years old (median of 18 days). Females in the 6-15 age group also took longer to clear the virus than males (median of 44 days for females compared to a median of 25.5 days for males). The median time to seropositivity, or the presence of antibodies in the blood, was 18 days, while the median time to reach adequate levels of neutralizing antibodies was 36 days. According to the team, neutralizing antibodies are important in potentially protecting a person from re-infection of the same virus. Although there is emerging data regarding this timing in adults with Covid-19, there is far less data when it comes to the pediatric population, the study said. "The takeaway here is that we can't let our guard down just because a child has antibodies or is no longer showing symptom. The continued role of good hygiene and social distancing remains critical," the study authors wrote. Recently, a study, published in the journal JAMA Pediatrics, revealed that children can shed Covid-19 virus even if they never develop symptoms or for long after symptoms have cleared. The report by the American Academy of Pediatrics and the Children's Hospital Association released on Monday said that nearly 4,80,000 children in the US have been infected with the Covid-19 since the pandemic hit the country earlier this year. SEE ALSO: <a href="https://www.businessinsider.in/thelife/personalities/news/us-magazine-fortune-released-its-annual-40-under-40-list-of-most-influential-people-under-the-age-of-40/slidelist/77906566.cms">Isha and Akash Ambani, Adar Poonawalla, Byju Raveendra — meet the Indians who made it to Fortune's ‘40 under 40’ list this year</a>

Coronavirus and its antibodies can coexist in young patients, says study

<ul><li>Around 40 per cent of <keyword id="8763838" type="UNKNOWN" weightage="20" keywordseo="covid-19">COVID-19</keyword> patients lost antibodies post their recovery from the disease, revealed a survey by the Ahmedabad civic body covering 1,800 previously infected people in the city. </li><li>The loss of antibodies makes people who have recovered from the disease susceptible to reinfection, said Dr Bhavin Solanki, medical officer of the Ahmedabad Municipal Corporation (AMC), on Friday. </li></ul> Around 40 per cent of COVID-19 patients lost antibodies post their recovery from the disease, revealed a survey by the Ahmedabad civic body covering 1,800 previously infected people in the city. The loss of antibodies makes people who have recovered from the disease susceptible to reinfection, said Dr Bhavin Solanki, medical officer of the Ahmedabad Municipal Corporation (AMC), on Friday. The survey was conducted on 1,800 persons, who tested positive for coronavirus between March and July through antigen tests, said Dr Jay Sheth, associate professor of civic-run MET Medical College. Developing antibodies means a person contracted COVID-19, recovered and subsequently developed them against the viral disease. "The survey has revealed that around 40 per cent of the recovered patients have lost antibodies, and antibodies disappear from several people in the long run after recovery," Solanki said. This suggests that people who have lost antibodies can contract COVID-19 again in the future, he said. "Till a vaccine is made available in the market, we must take precautionary measures such as social distancing and wearing masks," Solanki said. Voicing a similar concern, Dr Sheth said, "Absence of antibodies in 40 per cent of recovered persons suggests that they can get reinfected. A detailed study is required to analyse this phenomenon." Epidemic expert Dr R K Patel called for a detailed research into the results of the civic survey. "Coronavirus is a new subject for everyone. We still do not know how the virus behaves. It's a matter of research why antibodies disappear from recovered patients," said Dr Patel, director of U N Mehta Institute of Cardiology and Research Centre. The best defence against the viral infection is to practise social distancing and wear masks, Dr said. According to health experts, confirmed cases of reinfections have been reported in foreign countries. Ahmedabad district has so far recorded 32,013 COVID-19 cases and 1,741 deaths. SEE ALSO:<a href="https://www.businessinsider.in/retail/news/mukesh-ambani-plan-for-reliance-retails-5-7-billion-fund-raise-heres-what-we-know-so-far/articleshow/77924632.cms"> Mukesh Ambani’s plan for Reliance Retail’s $5.7 billion fundraise – Here’s what we know so far</a>

In Ahmedabad, around 40% COVID-10 patients have lost antibodies post recovery: Survey

<ul><li>Chief Minister <keyword id="43254" type="PERSON" weightage="20" keywordseo="Yogi-Adityanath">Yogi Adityanath</keyword> on Wednesday called for increasing contact tracing of <keyword id="1754604" type="PERSON" weightage="20" keywordseo="coronavirus">coronavirus</keyword> patients in Lucknow, Kanpur and Allahabad </li><li>According to the health department, the state reported 6,743 COVID-19 cases on Tuesday, out of which, 887 cases were found in Lucknow, 431 in Kanpur Nagar, 306 cases in Allahabad, among other places.</li></ul>Uttar Pradesh Chief Minister Yogi Adityanath on Wednesday called for increasing contact tracing of coronavirus patients in Lucknow, Kanpur and Allahabad. According to the health department, the state reported 6,743 COVID-19 cases on Tuesday, out of which, 887 cases were found in Lucknow, 431 in Kanpur Nagar, 306 cases in Allahabad, among other places. "Contact tracing has an important role in controlling the spread of COVID-19 infection. This work should be conducted in a systematic and effective manner. In Lucknow, Prayagraj and Kanpur, contact tracing should be increased," a statement quoted the chief minister as saying. He was speaking at a COVID-19 review meeting here. He said the state government was committed to protect the people from the infection and provide better treatment to all. Stating that training of paramedical staff should be expedited to increase the manpower in COVID hospitals, the CM said in order to keep the medical personnel safe from the infection, adequate PPE kits, gloves, masks and sanitizers should be made available to them. SEE ALSO:<a href="https://www.businessinsider.in/science/health/news/why-the-latest-surge-in-covid-19-infections-in-india-may-cause-more-deaths/articleshow/78011731.cms">What India’s rising COVID-19 infections don’t⁠ reveal — the lack of health infrastructure in remote areas</a>

UP CM calls for increasing COVID-19 contact tracing of patients in Lucknow, Kanpur and Allahabad

A Paytm employee, who was among the first 30 coronavirus cases in India, has recovered and was discharged from hospital after his last two results came negative, the digital payment company said on Friday. "Coronavirus affected employee from Paytm Gurgaon office has been discharged from hospital today evening and is on his way back home. He is completely fit and has had his last two results as negative. He has been prescribed self isolation for next 14 days and is required to stay at home," Paytm said in a tweet. The Paytm employee, who tested positive on March 5, had come in touch with 91 people in Gurgaon. "His relative (who was diagnosed contaminated through him within a week) as well has recovered and been discharged today and recommended self isolation for 14 days," Paytm said. Paytm has allowed all employees to work from home till March 31.

Coronavirus-infected Paytm employee fully recovered and discharged from hospital according to company

During the wake of the New Year 2020, the world confronted a dreadful virus 2019-nCoV, identified as a new member of the class of <keyword id="1754604" type="PERSON" weightage="20" keywordseo="coronavirus">coronavirus</keyword> that is known to cause common cold in humans. The WHO is now spreading awareness on what symptoms to watch for if you want to ascertain the contact of this virus in someone. <keyword id="8638019" type="UNKNOWN" weightage="20" keywordseo="symptoms-of-coronavirus">Symptoms of coronavirus</keyword> in patients Patients so far diagnosed with 2019-nCoV coronavirus are reported with mild or severe respiratory diseases and the symptoms noticed include fever, shortness of breath and cough. Medical experts warn that these symptoms might onset in the subjects in about 2 to 14 days from the date of exposure. What to do if 2019-nCoV Coronavirus symptoms are noticed If anyone you know happens to report the symptoms given above under suspected exposure to 2019-nCoV Coronavirus, it is necessary that you call the doctor at once and book an appointment for a detailed investigation. Useful medical advice for suspected cases of 2019-nCoV Coronavirus attack If you have been suspected of having contacted 2019-nCoV attack, it is essential that you follow the guidelines issued by the WHO in the good interest of you and the outside world. <ul><li>Stay at home except for the sake of getting medical care</li></ul>Except for the sake of getting medical care, it is advised that you stay at home. Neither the use of public transport nor attending schools and offices is the right thing to do. <ul><li>Stay in isolation</li></ul>To the best extent possible, isolate yourself from the rest of the family members. If possible, use a separate bathroom for yourself. Stay in a room away from the other members. <ul><li>Call the medical professional before visiting</li></ul>Before dropping in at the office of the medical professional, inform the person well in advance to get an appointment so that he or she ensures that other people are prevented from contacting the virus from you. <ul><li>Use a face marks</li></ul>When you need to be in the same room with other people, wear a face mask. If you can’t wear one, it is necessary for the other people in the room staying with you to wear their own face masks. Also, when you visit a medical practitioner, never forget to wear a face mask. <ul><li>Cover your face while coughing or sneezing</li></ul>Covering mouth and nose with a tissue is necessary while coughing or sneezing. Throw all the used tissues in a lined trash can as soon as possible. <ul><li>Wash your hands frequently</li></ul>Often wash your hands well with soap and water for about 20 seconds. Alcohol based hand sanitizer will work best if you are planning to go for a dry cleaning. Do not touch your nose, eyes and mouth with unwashed hands. <ul><li>Never share your things</li></ul>Do not share your utensils, glasses, cups, towels, bedding and other items with other people. After every use, wash them thoroughly with soap and water. <ul><li>Monitor the symptoms</li></ul>It is essential to get medical care as soon as possible when you feel difficulties in breathing. If you have been diagnosed with 2019-nCoV infection, monitor the symptoms in consultation with the doctor and keep the professional updated of the developments.

You Searched For "coronavirus patient updates" and got 7 results

COVID-19 crisis: Here are all the latest updates from India and around the world

PTI

An Indian ayurvedic drug is being tried on coronavirus patients in Mysore

Prabhjote Gill

Coronavirus and its antibodies can coexist in young patients, says study

IANS

In Ahmedabad, around 40% COVID-10 patients have lost antibodies post recovery: Survey

PTI

UP CM calls for increasing COVID-19 contact tracing of patients in Lucknow, Kanpur and Allahabad

PTI

Coronavirus-infected Paytm employee fully recovered and discharged from hospital according to company

PTI

Symptoms of coronavirus in patients

BI India Bureau

Popular Keywords

Buying Guides